RESUMO
BACKGROUND: Despite advances in perioperative care, the postoperative mortality rate after emergency oncological colonic resection remains high. Risk stratification may allow targeted perioperative optimization and cardiac risk stratification. This study aimed to test the hypothesis that the Revised Cardiac Risk Index (RCRI), a user-friendly tool, could identify patients who would benefit most from perioperative cardiac risk mitigation. METHODS: Patients who underwent emergency resection for colonic cancer from 2007 to 2017 and registered in the Swedish Colorectal Cancer Registry (SCRCR) were analysed retrospectively. These patients were cross-referenced by social security number to the Swedish National Board of Health and Welfare data set, a government registry of mortality, and co-morbidity data. RCRI scores were calculated for each patient and correlated with 90-day postoperative mortality risk, using Poisson regression with robust error of variance. RESULTS: Some 5703 patients met the study inclusion criteria. A linear increase in crude 90-day postoperative mortality was detected with increasing RCRI score (37.3 versus 11.3 per cent for RCRI 4 or more versus RCRI 1; P < 0.001). The adjusted 90-day all-cause mortality risk was also significantly increased (RCRI 4 or more versus RCRI 1: adjusted incidence rate ratio 2.07, 95 per cent c.i. 1.49 to 2.89; P < 0.001). CONCLUSION: This study documented an association between increasing cardiac risk and 90-day postoperative mortality. Those undergoing emergency colorectal surgery for cancer with a raised RCRI score should be considered high-risk patients who would most likely benefit from enhanced postoperative monitoring and critical care expertise.
Assuntos
Neoplasias do Colo , Complicações Pós-Operatórias , Neoplasias do Colo/cirurgia , Humanos , Complicações Pós-Operatórias/epidemiologia , Complicações Pós-Operatórias/etiologia , Estudos Retrospectivos , Medição de Risco , Fatores de RiscoRESUMO
BACKGROUND: Complicated acute biliary calculous disease poses clinical challenges. The European Society of Trauma and Emergency Surgery (ESTES) snapshot audit of complicated biliary calculous disease aims to make novel comparisons between self-reported institutional adherence to the Tokyo guidelines (TG18) and 'real-world' contemporary practice across Europe. METHODS: A preplanned analysis of a prospective observational multicentre audit that captured patients undergoing emergency admission for complicated biliary calculous disease (complicated cholecystitis, biliary pancreatitis, or choledocholithiasis with or without cholangitis) between 1 and 31 October 2018 was performed. An anonymized survey was administered to participating sites. RESULTS: Following an open call for participation, 25 centres from nine countries enrolled 338 patients. All centres completed the anonymized survey. Fifteen centres (60 per cent) self-reported that a minority of patients were treated surgically on index admission, favouring interval cholecystectomy. This was replicated in the snapshot audit, in which 152 of 338 patients (45·0 per cent) underwent index admission cholecystectomy, 17 (5·0 per cent) had interval cholecystectomy, and the remaining 169 (50·0 per cent) had not undergone surgery by the end of the 60-day follow-up. Centres that employed a dedicated acute care surgery model of care were more likely to perform index admission cholecystectomy compared with a traditional general surgery 'on call' service (57 versus 38 per cent respectively; odds ratio 2·14 (95 per cent c.i. 1·37 to 3·35), P < 0·001). Six centres (24 per cent) self-reported routinely performing blood cultures in acute cholecystitis; patient-level audit data revealed that blood cultures were done in 47 of 154 patients (30·5 per cent). No centre self-reported omitting antibiotics in the management of acute cholecystitis, and 144 of 154 (93·5 per cent) of patients in the snapshot audit received antibiotics during their index admission. CONCLUSION: Awareness of TG18 recommendations was high, but self-reported adherence and objective snapshot audit data showed low compliance with TG18 in patients with complicated acute biliary calculous disease.
ANTECEDENTES: La complicación aguda de la litiasis biliar (complicated acute biliary calculous disease, CABCD) plantea retos clínicos. Esta auditoría de la Sociedad Europea de Trauma y Cirugía de Urgencias (European Society of Trauma and Emergency Surgery, ESTES) de la CABCD tuvo como objetivo comparar el conocimiento teórico de las recomendaciones de Tokio (TG18) y la "práctica real" en Europa. MÉTODOS: Se efectuó un análisis pre-establecido de los datos de una auditoría prospectiva, observacional y multicéntrica que incluyó los pacientes ingresados de urgencia por CABCD (es decir, colecistitis complicada, pancreatitis biliar o coledocolitiasis con o sin colangitis) entre el 1 y el 31 de octubre de 2018. Además, se realizó una encuesta anónima en los centros participantes. RESULTADOS: Tras una convocatoria abierta, 25 centros de 9 países incluyeron 338 pacientes. Todos los centros completaron la encuesta anónima. El 60% de los centros reconocieron que trataban en el mismo ingreso una minoría de los pacientes y que favorecían la colecistectomía diferida. Ello se reprodujo en la auditoria, donde a 152/338 (44,9%) de los pacientes se realizó la colecistectomía en el mismo ingreso, a 17/338 (5%) se realizó una colecistectomía diferida y que a 169/338 (50%) todavía no se había realizado ninguna intervención en los 60 días de seguimiento. Los centros que seguían el Modelo de Atención Quirúrgica Urgente tenían mayores probabilidades de realizar la colecistectomía en el mismo ingreso en comparación con un servicio de cirugía general tradicional 'de guardia' (57% versus 38,4%, razón de oportunidades, odds ratio, OR 2,14 (i.c. del 95% 1,37-3,35), P < 0,001)). El 24% de los centros afirmaron realizar hemocultivos de rutina en la colecistitis aguda. Sin embargo, los datos de la auditoría revelaron que solamente 47/154 (30,5%) de los pacientes tenían hemocultivos. Ningún centro declaró no administrar antibióticos en el tratamiento de la colecistitis aguda, mientras que 144/154 (93,5%) de los pacientes de la auditoría no recibieron antibióticos durante el ingreso. CONCLUSIONES: El conocimiento de las recomendaciones de TG18 fue alto. Sin embargo, la observancia reconocida por los centros y los datos objetivos de la auditoría muestran que el cumplimiento en los pacientes con CABCD es bajo.
Assuntos
Colecistectomia Laparoscópica/métodos , Colecistite Aguda/cirurgia , Doenças da Vesícula Biliar/cirurgia , Fidelidade a Diretrizes , Autorrelato , Idoso , Idoso de 80 Anos ou mais , Colecistectomia Laparoscópica/efeitos adversos , Colecistite Aguda/diagnóstico por imagem , Feminino , Doenças da Vesícula Biliar/diagnóstico por imagem , Pesquisas sobre Atenção à Saúde , Hospitalização , Humanos , Internacionalidade , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , TóquioRESUMO
PURPOSE: The European Society for Trauma and Emergency Surgery (ESTES) identified the need for general and trauma surgeons involved in the management of critically ill surgical patients to embrace and learn both basic and advanced US skills. A steering group was created to address this deficit. METHODS: Modular UltraSound ESTES Course (MUSEC) is a modular blended-learning course. It incorporates pre-test/post-test examinations, pre-course online materials, didactic and interactive lectures, interactive case scenarios discussion with pathological US clips, hands-on practice on healthy volunteer models, and on original phantoms for simulating both pathological US findings and practicing US-guided interventional maneuvers. Four independent modules were provided. Surgical decision-making didactics were also included in the course curriculum. Learning gain (Δ of the rating of pre-test and post-test) was calculated for each module. An anonymous post-course satisfaction survey was also administered (16 questions with a Likert's 5-point scale of evaluation). RESULTS: Twenty-three MUSEC Courses were run in a 30 months period, training 416 doctors from 29 countries. A total of 52 modules were delivered. The mean pre-test and post-test grades were 8.3/12 and 10.7/12, respectively, yielding a significant mean learning gain of 28.9 % (p = 0.001). Post-course satisfaction survey got an overall ranking of 4.5/5. CONCLUSIONS: MUSEC is an effective and original educational format, enjoyed by candidates, that fills an educational gap for tailored US education as a procedural skill to acute care surgeons. Ongoing revisions should reduce the current limitations and increase the educational value, in terms of number of modules and post-course credentialing.
Assuntos
Educação Médica Continuada/métodos , Serviços Médicos de Emergência/métodos , Cirurgiões/educação , Traumatologia/métodos , Ultrassom/educação , Instrução por Computador/métodos , Avaliação Educacional , Humanos , Modelos Educacionais , Desenvolvimento de ProgramasRESUMO
BACKGROUND: An association between interval breast cancers (cancer detected after a normal mammogram and before the next scheduled mammogram) and tumour aggressiveness has been postulated which may reflect their relatively poor overall prognosis. The aim of this study was to evaluate known prognostic features of screen detected breast cancers compared to interval breast cancers. METHODS: Patients diagnosed with breast cancer between January 2010 and 2013 at a single unit of the National Breast Screening Program (NBSP) in Ireland and those between the ages of 50 and 65 diagnosed at a symptomatic breast clinic were included in the study. Patients who had not had a screening mammogram within the proceeding two years or had a previous history of breast cancer were excluded. Data were retrospectively collected on patient demographics, tumour type, grade, hormone receptor status and stage of disease at presentation. RESULTS: There were 915 patients included in the study, with 92% (n = 844) diagnosed through the NBSP. Ductal carcinoma in-situ accounted for 19% (n = 160) of screen-detected breast cancers but only 2.8% of interval cancers (p < 0.05). The most common type of invasive cancer was invasive ductal carcinoma. Tumour grade was significantly higher in interval breast cancers (p < 0.05). Interval cancers were identified at a significantly higher stage (Stage 1 versus 2; p < 0.001) than screen-detected cancers. Interval breast cancers were less likely to be ER positive (76% versus 81%; p < 0.05) and significantly more likely to over-express HER2 (20% vs 10%, p < 0.05) than screen-detected cancers. CONCLUSION: This study highlights the fact that interval cancers appear to have a number of adverse prognostic markers for overall breast cancer survival when compared to women with screen-detected breast cancers. Interval cancers were more likely to be invasive, of a higher grade and stage and with a greater predominance of HER2 and triple negative molecular subtypes. Therefore this heterogeneous group of tumours may be biologically more aggressive and account disproportionately to overall breast cancer mortality.
Assuntos
Neoplasias da Mama/diagnóstico , Carcinoma Ductal de Mama/diagnóstico , Carcinoma Intraductal não Infiltrante/diagnóstico , Detecção Precoce de Câncer/estatística & dados numéricos , Mamografia , Biomarcadores Tumorais , Neoplasias da Mama/química , Neoplasias da Mama/epidemiologia , Carcinoma Ductal de Mama/química , Carcinoma Ductal de Mama/epidemiologia , Carcinoma Intraductal não Infiltrante/química , Carcinoma Intraductal não Infiltrante/epidemiologia , Detecção Precoce de Câncer/métodos , Feminino , Humanos , Irlanda , Programas de Rastreamento , Pessoa de Meia-Idade , Programas Nacionais de Saúde , Gradação de Tumores , Invasividade Neoplásica , Estadiamento de Neoplasias , Receptor ErbB-2 , Estudos Retrospectivos , Avaliação de Sintomas , Fatores de TempoRESUMO
BACKGROUND: Penetrating trauma--the classical presentation of disorganised crime--can pose a challenge in their management due to their complexity and unpredictability. AIM: We examined the experience of one urban unit in the management of penetrating injuries to draw conclusions pertinent to other Irish centres. METHODS: A retrospective study was performed of all penetrating injuries presenting to the Emergency Department (ED) of Connolly Hospital, Dublin between January 2009 and December 2012. Information was collected from the Hospital Inpatient Enquiry database, theatre logbooks and ED records. RESULTS: One hundred and four patients presented with penetrating injuries in the given period. Four mortalities were recorded. Abdominal injury was recorded in 22% of patients; 26% had multiple injuries not involving the abdomen; 11% had an isolated thoracic injury. Fifty-seven percent required surgery, of which 40% required emergency or early surgical intervention. Laparotomy and laparoscopy were required in 14 and 7%, respectively; 5% required thoracotomy of which two had penetrating cardiac injuries, both of whom survived. CONCLUSIONS: Although many patients with penetrating trauma can be safely managed conservatively, our study shows that over half required surgical intervention. These data highlight the need for a trauma team in each Irish centre receiving trauma with a clear need for general surgeons on emergency on-call rotas to be experienced in trauma management. There is an urgent need to centralise the management of trauma to a limited number of designated trauma centres where expertise is available by surgeons with a special interest in trauma management.
Assuntos
Traumatismos Abdominais/epidemiologia , Traumatismo Múltiplo/epidemiologia , Traumatismos Torácicos/epidemiologia , Ferimentos Perfurantes/epidemiologia , Traumatismos Abdominais/cirurgia , Adolescente , Adulto , Idoso , Serviço Hospitalar de Emergência , Feminino , Traumatismos Cardíacos/epidemiologia , Traumatismos Cardíacos/cirurgia , Hospitais Urbanos/estatística & dados numéricos , Humanos , Incidência , Irlanda/epidemiologia , Masculino , Pessoa de Meia-Idade , Traumatismo Múltiplo/cirurgia , Estudos Retrospectivos , Traumatismos Torácicos/cirurgia , Ferimentos Perfurantes/mortalidade , Ferimentos Perfurantes/cirurgia , Adulto JovemRESUMO
INTRODUCTION: Surgery remains the mainstay of treatment for malignant melanoma. Despite previous studies examining the surgical interval (SI) between the diagnostic excision biopsy (DEB) and definitive surgical management there remains few guidelines regarding an optimal time interval. The aim of this study was to determine the SI between DEB and definitive surgery and elucidate factors associated with delays in management of malignant melanoma. METHODS: A retrospective study of 107 consecutive patients who had a DEB and subsequent wide local excision between January 2011 and June 2012 was performed. Mode of referral and dates of diagnostic biopsy/definitive surgery were documented. Patient demographics and tumour characteristics were reviewed. RESULTS: The mean age was 59.6 years, and male:female ratio was 1:1.3. Median duration of the SI was 41 ± 27 days (range 6-137 days). The SI was increased when dermatologists performed the DEB as opposed to general surgeons (p = 0.035). The anatomic location of the lesion predicted the SI, with lesions of the head/neck undergoing definitive excision 48 ± 32.3 days after DEB vs. 37.5 ± 22.6 days for all other sites (p = 0.001). Neither demographic factors nor histopathological prognostic features affected the SI. Reasons for a prolonged SI included referrals to different services and time for pre-operative planning. CONCLUSIONS: Significant variations were noted in the SI predominantly accounted for by mode of referral and location of the malignant melanoma. Further investigation is required to elucidate factors affecting the SI and its subsequent effect on patient outcomes.
Assuntos
Neoplasias de Cabeça e Pescoço/cirurgia , Melanoma/patologia , Melanoma/cirurgia , Neoplasias Cutâneas/patologia , Neoplasias Cutâneas/cirurgia , Tempo para o Tratamento , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Biópsia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Encaminhamento e Consulta , Estudos Retrospectivos , Pele/patologia , Adulto JovemRESUMO
An international intercomparison of the dosimetry of three beta particle emitting ophthalmic applicators was performed, which involved measurements with radiochromic film, thermoluminescence dosimeters (TLDs), alanine pellets, plastic scintillators, extrapolation ionization chambers, a small fixed-volume ionization chambers, a diode detector and a diamond detector. The sources studied were planar applicators of 90Sr-90Y and 106Ru-106Rh, and a concave applicator of 106Ru-106Rh. Comparisons were made of absolute dosimetry determined at 1 mm from the source surface in water or water-equivalent plastic, and relative dosimetry along and perpendicular to the source axes. The results of the intercomparison indicate that the various methods yield consistent absolute dosimetry results at the level of 10%-14% (one standard deviation) depending on the source. For relative dosimetry along the source axis at depths of 5 mm or less, the agreement was 3%-9% (one standard deviation) depending on the source and the depth. Crucial to the proper interpretation of the measurement results is an accurate knowledge of the detector geometry, i.e., sensitive volume and amount of insensitive covering material. From the results of these measurements, functions which describe the relative dose rate along and perpendicular to the source axes are suggested.
Assuntos
Braquiterapia/métodos , Oftalmopatias/radioterapia , Radiometria/instrumentação , Radiometria/métodos , Alanina/química , Partículas beta , Fenômenos Biofísicos , Biofísica , Modelos Estatísticos , Imagens de Fantasmas , Radioisótopos/uso terapêutico , Ródio/uso terapêutico , Rutênio/uso terapêutico , Radioisótopos de Estrôncio/uso terapêutico , Filme para Raios X , Radioisótopos de Ítrio/uso terapêuticoRESUMO
Safe and effective treatment with brachytherapy sources requires an accurate knowledge of the local tissue absorbed dose rate derived from the source reference air kerma rate. It is desirable that these air kerma rate measurements be traceable to national standards. The NPL has embarked on a programme that will enable the user to assay brachytherapy sources in a convenient manner prior to treatment. Calibration figures have been derived for the NPL secondary standard radionuclide calibrator for 192Ir brachytherapy sources manufactured by Amersham International plc. The calibration figures enable the user to accurately estimate the reference air kerma rate and activity of such sources by measuring the ionization chamber response. Calibration figures for other brachytherapy sources are also being derived.
Assuntos
Braquiterapia/normas , Radioisótopos de Irídio/normas , CalibragemRESUMO
In the therapeutic use of radionuclides, by far the most rapid growth in recent years is that of 125I seeds used for the treatment of prostate cancer. Large numbers of these seeds are used in each treatment and there is a need for a simple but accurate means of confirming their dose rates. This mechanism requires a transfer device for which the calibration factors are traceable to national standards. The NPL secondary standard radionuclide calibrator, because of its guaranteed reproducibility and traceable calibration procedure, is ideally suited for this purpose. A series of characterisation measurements have been performed on the NPL radionuclide calibrator in order to estimate the uncertainty levels that can be achieved and these are presented together with the relevant calibration factors for some typical seeds.
Assuntos
Braquiterapia/normas , Radioisótopos do Iodo/normas , Radioisótopos do Iodo/uso terapêutico , Neoplasias da Próstata/radioterapia , Humanos , Radioisótopos do Iodo/análise , Masculino , Radiometria/instrumentação , Radiometria/normas , Dosagem Radioterapêutica , Padrões de Referência , Tecnologia Radiológica , Reino UnidoRESUMO
INTRODUCTION: Oesophageal cancer usually presents with systemic disease, necessitating systemic therapy. Neo-adjuvant chemoradiotherapy improves short-term survival, but its long-term impact is disputed because of limited accrual, treatment-protocol heterogeneity and a short follow-up of randomised trials. AIMS: Long-term results of two simultaneous randomised controlled trials (RCTs) comparing neo-adjuvant chemo-radiotherapy and surgery (MMT) with surgical monotherapy were examined, and the response of adenocarcinoma (AC) and squamous cell carcinoma (SCC) to identical regimens compared. METHODS: Between 1990 and 1997, two RCTs were undertaken on 211 patients. Patients with AC (n=113) or SCC (n=98) were separately-randomised to identical protocols of MMT or surgical monotherapy. RESULTS: 211 patients were followed to 206 months; 104 patients were randomised to MMT (58 AC and 46 SCC, respectively) and 107 to surgery. MMT provided a significant survival-advantage over surgical monotherapy for AC (P=0.004), SCC (P=0.01). There was a 54% relative risk-reduction in lymph-node metastasis following MMT, compared with surgery (64% versus 29%, P<0.001). MMT produced a pathologic complete response (pCR) in 25% and 31% of AC and SCC, respectively. Survival advantage accrued to MMT, pCR and node-negative patients: AC pCR versus surgical monotherapy (P=0.001); residual disease following MMT versus surgical monotherapy (P=0.008); SCC pCR versus surgical monotherapy (P=0.033). CONCLUSIONS: A survival advantage for MMT persisted long-term in AC and was replicated in SCC. MMT produced loco-regional tumour down-staging to extinction in 25-31% of patients, potentially permitting personalised treatment in this cohort that avoids the morbidity and mortality associated with resection. Node-negative patients with residual localised disease following MMT had a survival advantage over node-negative patients following surgery alone, supporting a systemic effect on micro-metastatic disease.